J Cosmet Dermatol:含有透明质酸的可溶性微阵贴片可有效减少鱼尾纹和眼袋

2022-08-17 MedSci原创 MedSci原创

皮肤老化是与人类衰老相关的最明显的现象。眼睛周围的皮肤是皮肤组织中最容易老化的,因为它是面部皮肤中最薄的部分,并且要不断地进行运动。近年来,可溶性微阵(DMA)贴片技术被广泛用于医疗美容领域。

皮肤老化是与人类衰老相关的最明显的现象。眼睛周围的皮肤是皮肤组织中最容易老化的,因为它是面部皮肤中最薄的部分,并且要不断地进行运动。近年来,可溶性微阵(DMA)贴片技术被广泛用于医疗美容领域。但是,目前国内市场缺乏有关DMA贴片在美容方面的临床研究。因此,本研究对中国消费者进行了DMA贴片技术的临床疗效和安全性测试。

研究人员对30名存在鱼尾纹和眼袋的中国女性受试者进行了为期4周的临床疗效和安全性评估。在连续四周的时间里,将含有透明质酸的DMA贴片(HA-DMA)贴在受试者的眼下和眼角,每周三次。使用超声波测量皮肤紧实度和真皮层强度,并使用VISIA-CR和Primos Lite检测皮肤皱纹的变化。由专业皮肤科医生根据 "皮肤老化图谱第二卷:亚洲类型 "中的0-6级眼袋评估受试者的眼袋评级。

结果显示,HA-DMA贴片可有效改善参与者的鱼尾纹和眼袋。HA-DMA有效地提高了皮肤的紧致度,同时减少了鱼尾纹的数量、面积和体积,并降低了眼袋评级。所有指标的减少都具有统计学意义,且在治疗的短短一周内就有明显的积极效果。在测试期间,没有观察到与治疗有关的不良反应。

综上,在这项针对30名中国女性受试者的临床疗效试验中,HA-DMA在减少鱼尾纹和眼袋的同时,显示出良好的治疗效果,且无不良反应。因此,HA-DMA有望成为一种安全、有效和新颖的化妆品,用于改善皮肤老化的外观。

 

原始出处:

Yonghao Ma, et al., Efficacy and safety testing of dissolving microarray patches in Chinese subjects. J Cosmet Dermatol. 2022 Aug;21(8):3496-3502. doi: 10.1111/jocd.14594.  

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1783648, encodeId=fbfd1e836489e, content=<a href='/topic/show?id=f6c9511ec2' target=_blank style='color:#2F92EE;'>#CoSM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5117, encryptionId=f6c9511ec2, topicName=CoSM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Nov 03 07:47:47 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764172, encodeId=4d291e6417227, content=<a href='/topic/show?id=844492480bb' target=_blank style='color:#2F92EE;'>#贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92480, encryptionId=844492480bb, topicName=贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f237637156, createdName=12498b37m84暂无昵称, createdTime=Mon Jul 31 08:47:47 CST 2023, time=2023-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897055, encodeId=cd96189e055c3, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jul 30 14:47:47 CST 2023, time=2023-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276763, encodeId=c05712e6763f1, content=<a href='/topic/show?id=ec9e9482383' target=_blank style='color:#2F92EE;'>#透明质酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94823, encryptionId=ec9e9482383, topicName=透明质酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Tue Aug 16 14:47:47 CST 2022, time=2022-08-16, status=1, ipAttribution=)]
    2022-11-03 tcm99hq
  2. [GetPortalCommentsPageByObjectIdResponse(id=1783648, encodeId=fbfd1e836489e, content=<a href='/topic/show?id=f6c9511ec2' target=_blank style='color:#2F92EE;'>#CoSM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5117, encryptionId=f6c9511ec2, topicName=CoSM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Nov 03 07:47:47 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764172, encodeId=4d291e6417227, content=<a href='/topic/show?id=844492480bb' target=_blank style='color:#2F92EE;'>#贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92480, encryptionId=844492480bb, topicName=贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f237637156, createdName=12498b37m84暂无昵称, createdTime=Mon Jul 31 08:47:47 CST 2023, time=2023-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897055, encodeId=cd96189e055c3, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jul 30 14:47:47 CST 2023, time=2023-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276763, encodeId=c05712e6763f1, content=<a href='/topic/show?id=ec9e9482383' target=_blank style='color:#2F92EE;'>#透明质酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94823, encryptionId=ec9e9482383, topicName=透明质酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Tue Aug 16 14:47:47 CST 2022, time=2022-08-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1783648, encodeId=fbfd1e836489e, content=<a href='/topic/show?id=f6c9511ec2' target=_blank style='color:#2F92EE;'>#CoSM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5117, encryptionId=f6c9511ec2, topicName=CoSM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Nov 03 07:47:47 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764172, encodeId=4d291e6417227, content=<a href='/topic/show?id=844492480bb' target=_blank style='color:#2F92EE;'>#贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92480, encryptionId=844492480bb, topicName=贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f237637156, createdName=12498b37m84暂无昵称, createdTime=Mon Jul 31 08:47:47 CST 2023, time=2023-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897055, encodeId=cd96189e055c3, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jul 30 14:47:47 CST 2023, time=2023-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276763, encodeId=c05712e6763f1, content=<a href='/topic/show?id=ec9e9482383' target=_blank style='color:#2F92EE;'>#透明质酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94823, encryptionId=ec9e9482383, topicName=透明质酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Tue Aug 16 14:47:47 CST 2022, time=2022-08-16, status=1, ipAttribution=)]
    2023-07-30 一闲
  4. [GetPortalCommentsPageByObjectIdResponse(id=1783648, encodeId=fbfd1e836489e, content=<a href='/topic/show?id=f6c9511ec2' target=_blank style='color:#2F92EE;'>#CoSM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5117, encryptionId=f6c9511ec2, topicName=CoSM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74c2229, createdName=tcm99hq, createdTime=Thu Nov 03 07:47:47 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1764172, encodeId=4d291e6417227, content=<a href='/topic/show?id=844492480bb' target=_blank style='color:#2F92EE;'>#贴片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92480, encryptionId=844492480bb, topicName=贴片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f237637156, createdName=12498b37m84暂无昵称, createdTime=Mon Jul 31 08:47:47 CST 2023, time=2023-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897055, encodeId=cd96189e055c3, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Jul 30 14:47:47 CST 2023, time=2023-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276763, encodeId=c05712e6763f1, content=<a href='/topic/show?id=ec9e9482383' target=_blank style='color:#2F92EE;'>#透明质酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94823, encryptionId=ec9e9482383, topicName=透明质酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c77e138, createdName=kalseyzl, createdTime=Tue Aug 16 14:47:47 CST 2022, time=2022-08-16, status=1, ipAttribution=)]